Han Y, Wang Q, Chen Y, Wu H, et al. Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as
first-line treatment for advanced gastric/gastroesophageal junction
adenocarcinoma: a phase ii single-arm trial. BMC Cancer 2026;26:546.
PMID: 41840368
|